Clinical Trials Sponsored by Ectosense NV

Total 371 results

Ectosense NV

Unknown

NightOwl SpO2 Calibration Study (NOSCS)

Pulse Oximeter Calibration

Belgium
Ectosense NV

Unknown

NightOwl Pulse Oximeter Calibration Study (NPOCS)

Pulse Oximeter Calibration

Belgium
Ectosense NV

Active, not recruiting

A Validation Study of the NightOwl Home Sleep Apnea Test

Sleep Apnea

United States
Ectosense NV

Completed

A Validation Study of the NightOwl PAT-based Home Sleep Apnea Test

Sleep Apnea

United States
Ectosense NV
Ziekenhuis Oost-Limburg

Unknown

Prospective Validation Study of a Novel Type IV Home Sleep Apnea Test

Sleep Apnea

Belgium
Ectosense NV
Ziekenhuis Oost-Limburg

Unknown

Extensive Prospective Validation Study of the NightOwl Home Sleep Apnea Test

Sleep Apnea

Belgium
Echosense Ltd.

Withdrawn

Evaluation of Pulmonary Doppler Signals in Patients With Systemic Sclerosis(SSc)

Systemic Sclerosis | Pulmonary Hypertension

Israel
Echosense Ltd.

Completed

Changes in Doppler Signals From the Lung Due to Cardiac Resynchronization in Heart Failure Patients

Change in LDS Signals Due to Cardiac Synchronization Therapy

United States
Echosense Ltd.

Completed

The Use of a Ultra-sound of the Lung to Diagnose Lung Diseases

Pulmonary Pathologies | Cardio-pulmonary Diseases

Israel
Echosense Ltd.

Terminated

Measuring Blood Pressure in the Lung Circulation With Sonar Technology (Echo-Doppler)

Pulmonary Arterial Hypertension

Israel
Echosense Ltd.

Terminated

Measurements and Characterization of Doppler Signals From the Right Chest in Pediatric and Adult Patients

Pulmonary Hypertension

United States
Echosense Ltd.

Withdrawn

Evaluating Pulmonary Arterial Hypertension in Patients With Systemic Sclerosis

Systemic Sclerosis | Pulmonary Hypertension
Echosense Ltd.

Terminated

Pulmonary Blood Flow Measurements in CHF Patients

Congestive Heart Failure (CHF)

United States
Echosense Ltd.

Terminated

Evaluation of the Diagnostic Value of the TPD System in Determining ADHF Causing Acute Dyspnea

ADHF

United States
Echosense Ltd.

Terminated

Diagnosis of Pulmonary Embolism by Doppler Signals

Pulmonary Embolism

Israel
Echosense Ltd.

Completed

Measurements of Doppler Signals Noninvasively From the Lung in Congestive Heart Failure

Pulmonary Edema

Israel
Echosense Ltd.

Terminated

Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by Ultrasound

Systemic Sclerosis | Pulmonary Hypertension

Israel
Echosense Ltd.

Terminated

Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc)

Systemic Sclerosis | Pulmonary Hypertension

Israel
Echosense Ltd.

Withdrawn

Evaluation of Lung Doppler Signals in Patients Presenting to EMD

Pneumonia | COPD Exacerbation | Pulmonary Embolism | Acute Cardiovascular | CHF Exacerbation

Israel
Echosense Ltd.

Terminated

Monitoring and Characterization of Coronary Flow By Transthoracic Parametric Doppler (TPD) During Exercise Stress Test

Coronary Artery Disease

Israel
Echosense Ltd.

Withdrawn

Evaluation of Blood Flow Patterns in Lung Blood Vessels Using Ultrasound Technique in Patients With Congestive Heart Failure

Congestive Heart Failure (CHF)

United States
Echosens

Recruiting

Optimization of Spleen VCTE Examinations With FibroScan

Spleen; Fibrosis

Spain, Netherlands, Romania
Echosens

Completed

Validation of the Second Generation of the Controlled Attenuation Parameter (CAP) Using the MRI-PDFF as Reference

Chronic Liver Disease

France
Echosens

Completed

Spleen Stiffness Measurement With FibroScan

Cirrhosis

France, Italy, Romania, United Kingdom
Echosens

Completed

Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference.

Non-alcoholic Fatty Liver Disease

United Kingdom
Echosens

Recruiting

Validation of the New Vibration-guided FibroScan Examination

Liver Diseases

France
Echosens

Completed

Performances Evaluation of New FibroScan Probes Dedicated to Morbidly Obese Patients

Obesity, Morbid | Liver Fibrosis

France
Echosens

Completed

Development of Predictive Indicators of Homogeneous Propagation of Ultrasound and Elastic Waves During VCTE Examination

Liver Fibrosis

France
Echosens

Completed

Fibroscan® and Its Dedicated Probes Efficiency in Obese Patients

Cirrhosis | Liver Fibrosis

Canada
Qompium NV

Recruiting

Combining Accelerometer, Gyroscope, Sound, Electrocardiography and Photoplethysmography Data in Cardiac Monitoring (CARDS-pilot)

Atrial Fibrillation

Belgium
Galapagos NV

Recruiting

Study to Measure Filgotinib in the Blood of Children and Teenagers With Arthritis Taking Filgotinib (SCALESIA)

Juvenile Idiopathic Arthritis

Spain, Germany, United Kingdom, France, Poland
Galapagos NV

Recruiting

A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus Erythematosus (GALACELA)

Systemic Lupus Erythematosus

United States, Spain, Bulgaria, France, Georgia, Puerto Rico, Argentina, Poland, Hungary, Germany, Chile, Peru
Barco NV

Recruiting

Research in the Development of a New Type of Digital Dermatoscope for Skin Cancer (DermScan)

Skin Diseases | Skin Cancer

Belgium
Galapagos NV

Active, not recruiting

Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis (FILOSOPHY)

Rheumatoid Arthritis

Belgium, Netherlands, Spain, Germany, Italy, United Kingdom
Oystershell NV

Completed

Efficacy of a Cryogenic Medical Device on Skin Tags Versus a Comparator Product.

Skin Tags

France
Galapagos NV

Terminated

A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in Remission (CAPYBARA)

Ulcerative Colitis

United States, Germany, Korea, Republic of, Spain, France, Hungary, United Kingdom, Poland, Belgium, Czechia, Italy, South Africa, Taiwan
Galapagos NV

Completed

A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Ulcerative Colitis (SEA TURTLE)

Ulcerative Colitis

Ukraine, Georgia, Poland, Moldova, Republic of
Galapagos NV

Terminated

A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care (ISABELA1)

Idiopathic Pulmonary Fibrosis

United States, Spain, Japan, Belgium, Taiwan, Denmark, Germany, United Kingdom, Greece, Australia, Czechia, Brazil, Chile, Peru, Turkey
Galapagos NV

Terminated

A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care (ISABELA2)

Idiopathic Pulmonary Fibrosis

United States, Netherlands, Korea, Republic of, Israel, Japan, New Zealand, France, Italy, Argentina, Germany, Hungary, South Africa, Poland, Canada, Mexico
Galapagos NV

Completed

A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Moderately to Severely Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate (LADYBUG)

Rheumatoid Arthritis

Ukraine, Georgia, Bulgaria, Poland
Oystershell NV

Completed

A Clinical Trial to Evaluate Efficacy and Safety of a Water-soluble Head Lice Product.

Head Lice | Pediculosis Capitis

United States
Galapagos NV

Completed

Evaluation of Mass Balance and Absolute Bioavailability of GLPG3667

Healthy

United Kingdom
Galapagos NV

Completed

A Study to Evaluate How Well Single and Multiple Doses of GLPG4399 Are Tolerated in Healthy, Adult Subjects

Healthy

Canada
Galapagos NV

Completed

A Clinical Study to Test How Effective and Safe GLPG1205 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) (PINTA)

Idiopathic Pulmonary Fibrosis

Slovakia, Finland, France, Sweden, Bulgaria, Croatia, Oman, Romania, Ukraine
Galapagos NV

Completed

Evaluation of Mass Balance and Absolute Bioavailability of GLPG3970

Healthy

United Kingdom
Oystershell NV

Completed

Clinical Evaluation of Efficacy and Safety of a Medical Device for the Treatment of Toenail Onychomycosis

Onychomycosis of Toenail

Tunisia
Galapagos NV

Completed

Evaluation of Mass Balance and Absolute Bioavailability of GLPG1205

Healthy

United Kingdom
Galapagos NV

Completed

Drug-drug Interaction Study With GLPG3667 and Midazolam in Healthy Subjects

Healthy

United Kingdom
Galapagos NV

Terminated

A Study to Evaluate the Safety and Tolerability of MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Participants With Moderate to Severe Atopic Dermatitis (GECKO)

Atopic Dermatitis

United States
Galapagos NV

Completed

A Study Investigating the Safety, Absorption and Elimination of GLPG3312, a New Drug in the Treatment of Inflammatory Diseases

Healthy

Netherlands

3

Subscribe